CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer

Stock Information for Sensus Healthcare Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sensus Healthcare Inc.

Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
Sensus Healthcare Reports Third Quarter 2025 Financial Results
Sensus Healthcare Named to TIME's America's Growth Leaders of 2026
Sensus Healthcare Announces the Passing of Director Bill McCall
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.